Key facts
- Is zopiclone a benzodiazepine, in one line: no. Chemically it is a cyclopyrrolone, not a benzodiazepine, but it works at the same “benzodiazepine site” on the brain’s GABA-A receptor, so it behaves a lot like one. Our zopiclone guide covers the basics.
- Zopiclone is one of the “Z-drugs,” a group of sleep medicines that also includes eszopiclone (Lunesta), zolpidem (Ambien) and zaleplon.
- Zopiclone has never been approved by the FDA, so US pharmacies can’t dispense it. The DEA still lists it in Schedule IV, the same schedule as benzodiazepines.
- It carries many of the same risks as benzodiazepines: dependence, withdrawal, next-day drowsiness, falls in older adults and dangerous sedation with alcohol or opioids.
People ask “is zopiclone a benzodiazepine?” for good reasons. Maybe a relative was prescribed it abroad, a doctor called it a “benzo-like” drug, or you’re trying to work out whether a warning about benzodiazepines applies to it. The short answer is that zopiclone is not a benzodiazepine by chemistry, but it acts on the same switch in the brain. That’s why doctors, regulators and drug labels often discuss the two together.
This guide explains the difference in plain language, what it means for dependence and safety, and how things stand for US readers, where zopiclone isn’t sold.
Is zopiclone a benzodiazepine? The chemistry answer
Benzodiazepines such as diazepam (Valium), lorazepam (Ativan) and temazepam (Restoril) share a specific chemical backbone: a benzene ring fused to a diazepine ring. That shared structure is where the name comes from.
Zopiclone doesn’t have that backbone. A classic drug review in Drugs described it as “the first of the cyclopyrrolones,” a separate chemical class, while noting that its effects were similar to those of the benzodiazepines. The FDA label for eszopiclone, the active half of the zopiclone molecule sold in the US as Lunesta, uses the same language. It calls eszopiclone a nonbenzodiazepine hypnotic of the cyclopyrrolone class and says that although its structure is unrelated to benzodiazepines, it “shares some of the pharmacologic properties of the benzodiazepines.”
So on paper, zopiclone sits outside the benzodiazepine family. In the body, it’s a close cousin.
Why zopiclone acts like a benzodiazepine
Your brain uses a chemical messenger called GABA to calm nerve activity. Benzodiazepines act on “benzodiazepine receptors”, which are part of the GABA-A receptor. When a benzodiazepine attaches there, GABA’s calming signal gets stronger, which leads to sleepiness, less anxiety and muscle relaxation.
Zopiclone lands at the same spot, or very close to it. Early research found its binding occurs at the benzodiazepine receptor complex or a site closely linked to it. The Lunesta label says the effect is probably related to binding sites “located close to or allosterically coupled to benzodiazepine receptors.” That’s why US geriatric experts use the formal name “nonbenzodiazepine benzodiazepine receptor agonist hypnotics” for the Z-drugs: not benzodiazepines, but drugs that act on the benzodiazepine receptor.
A practical sign of this shared target: in an overdose, the label notes that flumazenil “may be useful”. Flumazenil is the hospital drug that blocks the benzodiazepine receptor, and only clinicians decide whether to use it.
Zopiclone vs benzodiazepines at a glance
| Zopiclone | Benzodiazepine sleep medicines (e.g., temazepam, triazolam) | |
|---|---|---|
| Chemical class | Cyclopyrrolone (“Z-drug”) | Benzodiazepine |
| Where it acts | Benzodiazepine site on the GABA-A receptor (or a closely linked site) | Benzodiazepine site on the GABA-A receptor |
| Main use | Short-term insomnia only | Insomnia, and (for other benzodiazepines) anxiety, seizures, alcohol withdrawal |
| Half-life | About 5 hours | Ranges from short to very long, depending on the drug |
| US federal schedule | Schedule IV | Schedule IV |
| FDA-approved in the US? | No | Yes (several) |
| Dependence and withdrawal | Yes, possible | Yes, well documented |
| FDA boxed warning | Complex sleep behaviors (on US Z-drugs; zopiclone itself has no US label) | Abuse, addiction, dependence and withdrawal; risks with opioids |
The US status: not approved, but still controlled
Zopiclone has never been approved by the FDA, so US pharmacies cannot legally fill it. Even so, the DEA treats it as a controlled substance. In 2005 the agency added “Zopiclone” to the Schedule IV list in 21 CFR 1308.14, the same schedule that holds the benzodiazepines, zolpidem and eszopiclone. The Lunesta label states plainly that other Schedule IV substances include benzodiazepines and the Z-drugs. That Schedule IV listing is also why mailing or carrying zopiclone into the country runs into DEA rules, as our guide to bringing zopiclone into the US explains.
The closest US option is eszopiclone (Lunesta), which is FDA-approved for insomnia. Our comparison of zopiclone vs eszopiclone explains how the two relate.
Does “not a benzo” mean safer?
Not by much. When the Z-drugs arrived, they were promoted as cleaner alternatives to benzodiazepines. Some advantages are real: zopiclone is used only for sleep and has a shorter half-life than many older benzodiazepines. But the risks overlap a great deal.
Dependence and withdrawal
A systematic review in Canadian Family Physician found evidence of abuse and dependence on zopiclone in case reports and small patient series. Some people had severe rebound insomnia, anxiety, tremor, a racing heart and even seizures after stopping. Abuse was more common in people with past substance use or psychiatric illness. The author concluded that while the Z-drugs may carry less addiction risk than most benzodiazepines, the comparison studies conflict, and prescriptions should be short. An earlier review found zopiclone did not have a high dependence potential in people without a history of drug misuse, which is the lower-risk group.
For the US product eszopiclone, MedlinePlus notes it is a controlled substance that can cause withdrawal if stopped suddenly, with symptoms such as anxiety, unusual dreams and stomach or muscle cramps. Don’t stop a sleep medicine on your own after regular use; your prescriber can plan how to come off it.
Different boxed warnings
In 2020 the FDA required an updated boxed warning for all benzodiazepine medicines about abuse, addiction, physical dependence and withdrawal. The Z-drugs aren’t on that list. Instead, they carry their own boxed warning, added in 2019, for complex sleep behaviors such as sleepwalking and sleep driving that have led to serious injuries and deaths. The FDA’s consumer guide to Z-drugs explains those risks for eszopiclone, zaleplon and zolpidem. Different label, but no less serious.
Older adults
The American Geriatrics Society’s 2023 Beers Criteria, a US list of medicines older adults should usually avoid, puts the Z-drugs right next to benzodiazepines. It says the Z-drugs have adverse events similar to those of benzodiazepines in people 65 and older, including delirium, falls, fractures and car crashes, with only small gains in sleep. Our zopiclone side effects guide covers next-day drowsiness and falls in more detail.
Alcohol, opioids and other sedatives
Like benzodiazepines, Z-drugs add to the effects of other central nervous system depressants. The Lunesta label warns about combining it with opioids, other sedatives and alcohol, and advises not taking it on a night you’ve been drinking. Mixing these can slow breathing to a dangerous level.
When to get emergency help: call 911 if someone who took a sleep medicine is very hard to wake, is breathing slowly or shallowly, has blue or gray lips, or was also drinking or taking opioids. For questions about a possible overdose, call Poison Help at 1-800-222-1222. If you’re having thoughts of suicide, call or text 988.
Where zopiclone fits among the Z-drugs
The four Z-drugs differ mostly in how long they last. Zaleplon wears off fastest, zolpidem sits in the middle, and zopiclone and eszopiclone last longest, which helps with staying asleep but raises the chance of morning grogginess. See zopiclone vs zolpidem vs zaleplon for a side-by-side comparison.
Whatever the drug, US guidelines don’t put pills first for long-term sleep problems. The American College of Physicians recommends cognitive behavioral therapy for insomnia (CBT-I) as the first treatment for chronic insomnia. Our guide to zopiclone for insomnia covers what US patients use instead.
Questions to ask your prescriber
- Is the sleep medicine you’re suggesting a benzodiazepine, a Z-drug or something else, and why that one?
- How long should I take it, and what’s the plan for stopping?
- Could it interact with my other medicines, especially pain medicines, anxiety medicines or anything else that makes me drowsy?
- Should I try CBT-I first, or alongside the medicine?
- I took zopiclone abroad. What’s the closest FDA-approved option for me here?
FAQ
Is zopiclone a benzodiazepine?
No. Zopiclone is a cyclopyrrolone, a different chemical class. It does act at the benzodiazepine site of the GABA-A receptor, so its effects and many of its risks are similar to those of benzodiazepines.
Is zopiclone a controlled substance in the US?
Yes. The DEA placed zopiclone in Schedule IV in 2005, the same schedule as benzodiazepines, zolpidem and eszopiclone. It has never been approved by the FDA, so US pharmacies can’t dispense it.
Is zopiclone less addictive than benzodiazepines?
Possibly somewhat, but the evidence is mixed. Reviews describe dependence, abuse and withdrawal with zopiclone, especially with long-term use or a history of substance use. It’s meant for short-term use only.
Is eszopiclone (Lunesta) a benzodiazepine?
No. Its FDA label calls it a nonbenzodiazepine hypnotic of the cyclopyrrolone class. Like zopiclone, it shares some pharmacologic properties with benzodiazepines and is a Schedule IV controlled substance.
Can you take zopiclone with a benzodiazepine or alcohol?
Combining sedatives, alcohol or opioids increases the risk of dangerous drowsiness and slowed breathing. Only take sleep medicines in combinations your prescriber has approved, and don’t take them on a night you’ve been drinking.
Related guides
- Zopiclone: What It Is and Why It Isn’t Sold in the US
- Zopiclone vs Eszopiclone (Lunesta): The US Equivalent Explained
- Zopiclone Side Effects: Metallic Taste, Next-Day Drowsiness and More
- Zopiclone vs Zolpidem (Ambien) vs Zaleplon: Z-Drugs Compared
- Zopiclone for Insomnia: How It Works and What US Patients Use Instead
- Can You Buy Zopiclone for Insomnia in the US? Prescription Rules and Legal Options
- Complex Sleep Behaviors: The FDA Boxed Warning on Z-Drugs
- Zopiclone Dependence, Tolerance and Withdrawal
- Zopiclone and Alcohol, Opioids and Other Interactions
- Sleep Medicines in Older Adults: Falls and the Beers Criteria
- CBT-I and Non-Drug Insomnia Treatments
- Bringing Zopiclone into the US: FDA and DEA Import Rules
- Getting a Lunesta (Eszopiclone) Prescription for Insomnia
Sources
- Goa KL, Heel RC. Zopiclone: a review of its pharmacodynamic and pharmacokinetic properties. Drugs. 1986 (PubMed)
- LUNESTA (eszopiclone) prescribing information, FDA
- Benzodiazepines, StatPearls, NCBI Bookshelf (updated January 2024)
- Terzano MG, et al. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf. 2003 (PubMed)
- DEA final rule placing zopiclone in Schedule IV, Federal Register, April 4, 2005 (govinfo)
- Cimolai N. Zopiclone: is it a pharmacologic agent for abuse? Can Fam Physician. 2007 (PubMed)
- Noble S, et al. Zopiclone: an update of its pharmacology, clinical efficacy and tolerability. Drugs. 1998 (PubMed)
- Eszopiclone, MedlinePlus Drug Information (revised February 2026)
- FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class (September 2020)
- FDA: Certain prescription insomnia medicines, new boxed warning (April 2019)
- FDA Consumer Update: Taking Z-drugs for Insomnia? Know the Risks
- American Geriatrics Society 2023 updated AGS Beers Criteria. J Am Geriatr Soc. 2023 (PubMed)
- American College of Physicians: CBT as initial treatment for chronic insomnia (May 2016)
